From: Ceramide synthase 4 overexpression exerts oncogenic properties in breast cancer
MSigDB Hallmark 2020 term | Overlap | P-value | Adjusted P-value | Odds ratio | Combined score |
---|---|---|---|---|---|
Epithelial−Mesenchymal Transition | 15 (200) | 3.94E − 15 | 1.42E-13 | 23.52782194 | 780.3360494 |
TNF-α Signaling via NF-κB | 14 (200) | 9.13E − 14 | 1.64E-12 | 21.52360916 | 646.2376942 |
Hypoxia | 10 (200) | 1.03E − 08 | 1.24E-07 | 14.22278298 | 261.5745424 |
Complement | 7 (200) | 1.97E − 05 | 1.77E-04 | 9.412871557 | 102.0059035 |
Apical Junction | 6 (200) | 1.85E − 04 | 1.11E-03 | 7.921944035 | 68.10278008 |
Inflammatory Response | 6 (200) | 1.85E − 04 | 1.11E-03 | 7.921944035 | 68.10278008 |
IL-2/STAT5 Signaling | 5 (199) | 1.44E − 03 | 4.81E-03 | 6.516983875 | 42.65610088 |
mTORC1 Signaling | 5 (200) | 1.47E − 03 | 4.81E-03 | 6.483234714 | 42.29192897 |
E2F Targets | 5 (200) | 1.47E − 03 | 4.81E-03 | 6.483234714 | 42.29192897 |
p53 Pathway | 5 (200) | 1.47E − 03 | 4.81E-03 | 6.483234714 | 42.29192897 |